The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 1,001–1,100 of 1,810
Bhushan, R., Trivedi, R., Raj, R., Rani, A., Rai, S., Tripathi, A., Rawat, S. G., Kumar, A., Kumar, D., & Dubey, P. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-88485-4 · Cited by 5
Hakim, R., Alqerafi, A. A., Malibari, W., Allhybi, A. K., Aslab, B. K. A., Hafez, A. A., Sawad, M. B., & Almalky, N. A. (2023) · Cureus · doi:10.7759/cureus.46937 · Cited by 5
Li, Y., Zheng, H., Jiang, W., Chi, Y., Meng, Y., Mo, Y., Chen, C., Qu, B., He, J., & Chen, F. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07801-y · Cited by 4
Amer, A., Ayoub, A., Brousseau, É., & Auger, N. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313653 · Cited by 2
Methods for assessing insulin resistance in gestational diabetes mellitus
Волкова, Н. И., Davidenko, I. Y., Sorokina, Y. A., Degtyareva, Y. S., & London, E. M. (2022) · Medical Herald of the South of Russia · doi:10.21886/2219-8075-2022-13-1-5-12 · Cited by 9
Gao, B.-B., Zhang, Q., Dong, S.-Q., Gao, F., Liu, X., Wei, J., & Yu, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s436178 · Cited by 4
Msollo, S. S., Martin, H., Mwanri, A. W., & Petrucka, P. M. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04838-1 · Cited by 5
Ma, Y., Sun, J., Yuan, N., Xin, S., Zhao, D., & Zhang, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-13051-x · Cited by 4
Cichocka, E., & Gumprecht, J. (2022) · Medicina · doi:10.3390/medicina58030398 · Cited by 3
“Environmental factors, including particularly the obesity epidemic and higher age of pregnant women, are also involved in the manifestation of the disease [3].”
BackgroundChallenge of diabetes mellitus and researchers’ contributions to its control
Odularu, A. T., & Ajibade, P. A. (2021) · Open Chemistry · doi:10.1515/chem-2020-0153 · Cited by 6
“Aziz et al. used female Sprague–Dawley rats as the GDM animal models [91].”
BackgroundInfluentialBayramoğlu, D., Akdemir, C., Özler, S., & Bayramoğlu, Z. (2026) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-025-08289-9 · Cited by 7
“The placenta houses a specialized subset of macrophages known as Hofbauer cells, which play a central role at the maternal–fetal interface in maintaining immune tolerance [7].”
Chong, H., Li, J., Chen, C., Wang, W., Liao, D., & Zhang, K. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24627 · Cited by 2
Reynolds, C. M. (2023) · The Journal of Physiology · doi:10.1113/jp284407 · Cited by 3
“As with obesity during pregnancy, GDM increases the risk of developing type 2 diabetes in mothers and their offspring (Plows et al., 2018).”
BackgroundSelf-citationMortensen, G. A., Schmidt, H., Predrag Radivojac, A., Ye, Y., & Haas, D. M. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03155-25 · Cited by 3
“SCFAs such as propionate and butyrate are known to modulate insulin sensitivity, endothelial function, and immune tolerance, all of which are disrupted in GH and GDM (7, 8).”
Liu, Q., Gui, J., & Wu, L. (2024) · Placenta · doi:10.1016/j.placenta.2024.04.006 · Cited by 4
Racial/Ethnic and Nativity Disparities in Gestational Diabetes Mellitus, United States 2018–2021
Kim, M. K., James-Todd, T. M., Chie, L., Werner, E. F., & Chu, M. T. (2025) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-025-02376-y · Cited by 5
Pathophysiological relevance and therapeutic outlook of GPR43 in atherosclerosis
Tang, M.-Y., Xie, H., Tao, J.-T., Zhang, C., Luo, Y.-H., Zhang, C., Peng, S.-Q., Xie, L.-X., Lv, W.-B., Zhang, C., et al. (2024) · Biochemistry and Cell Biology · doi:10.1139/bcb-2024-0053 · Cited by 2
Качалов, К. С., Solomina, A. S., & Rodina, A. V. (2024) · Journal Biomed · doi:10.33647/2713-0428-20-3e-191-196 · Cited by 2
Chen, F., Fei, X., Li, M., Zhang, Z., Zhu, W., Zhang, M., Chen, X., Xu, J., Zhang, M., Shen, Y., et al. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01188-2 · Cited by 2
“Extended author information available on the last page of the article contribute to the high incidence of future progression from GDM to T2DM after delivery [8].”
BackgroundJia, Y., Jiang, H., Fu, Y., Li, Y., & Wang, H. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06592-y · Cited by 4
“…previous two studies [7, 47] showed that weight gain during pregnancy is a protective factor for the incidence of gestational diabetes and pregnant women with insufficient GWG are more likely to develop gestational diabetes, which is contrary to the physiological mechanism of pregnancy [50].”
ResultTeotia, N., Singh, A., Kunwar, S., Kumari, S., & Rathore, B. S. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14989 · Cited by 2
“The pathogenesis of gestational diabetes revolves around insulin resistance and relative pancreatic β-cell dysfunction.(5,6)”
BackgroundChen, B., Ma, T., Liu, Y., Wang, M., Yin, T., & Han, Y. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.114931 · Cited by 3
First trimester gut microbiome induces Inflammation-dependent gestational diabetes phenotype in micePreprint
Pinto, Y., Frishman, S., Turjeman, S. C., Eshel, A., Nuriel‐Ohayon, M., Ziv, O., Walters, W. A., Parsonnet, J., Ley, C., Johnson, E. L., et al. (2021) · medRxiv · doi:10.1101/2021.09.17.21262268 · Cited by 2
Kawamura, M., Mau, M. K. L. M., Soon, R. A., & Yamasato, K. S. (2022) · PubMed · Cited by 3
Peng, Y., Qiu, X., Wang, L., Li, X., & Huo, X.-Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1026587 · Cited by 3
Lin, J., Horswell, R. L., Chu, S. T., Dumas, S. A., & Hu, G. (2024) · Journal of Women s Health · doi:10.1089/jwh.2023.0746 · Cited by 2
“…of GDM is due to multiple risk factors, such as a lower SES, physical inactivity, obesity, family history of diabetes, advanced maternal age, and the growth of minority populations with a higher risk of GDM. 15,31 36 Therefore, the Medicaid population typically has more risk factors for GDM.”
Sleep health predicted glucose metabolism among pregnant women: A prospective cohort study
Wang, Y., Chen, P., Wang, J., Lin, Q., Hong, L., Izci‐Balserak, B., Yuan, J., Zhao, R., & Zhu, B. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111570 · Cited by 4
Association of Parity with Type 2 Diabetes Mellitus in Japan
Wang, H., Iwama, N., Yuwaki, K., Nakamichi, Y., Hamada, H., Tomita, H., Tagami, K., Kudo, R., Kumagai, N., Metoki, H., et al. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01752-z · Cited by 2
“As the dysfunction could be progressive after delivery, GDM is associated with a high risk of T2DM [36].”
Payot, M. D., Villavieja, A., & Pineda-Cortel, M. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910527 · Cited by 5
“At the molecular level, this resistance typically arises from impaired insulin signaling pathways [23].”
BackgroundMekonen, E. G., Gebrehana, D. A., Tamir, T. T., Zegeye, A. F., & Tekeba, B. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02018-8 · Cited by 4
“Numerous negative pregnancy outcomes, including pre-eclampsia, macrosomia, birth trauma, perinatal death, and newborn cardiac, respiratory, and metabolic issues, have been linked to GDM [11].”
Ye, Y., Qin, K.-Z., Xiong, Y., Wu, J., Zhou, Q., Xiao, X., & Li, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.743170 · Cited by 4
“The selection of the covariates to be included in the models was based on findings in previous scientific literature (12, 13), and variables of maternal age, BMI and HbA1c level were retained in the model irrespective of statistical significance because all these covariates had a theoretical association with the outco…”
MethodGambaran Kadar Glukosa dan Total Kolesterol pada Wanita Hamil di Kabupaten Bangli, Bali
Bekti, H. S., Dewi, N. N. A., Rinawati, L. P., et al. (2022) · Jurnal Bidan Cerdas · doi:10.33860/jbc.v4i2.1024 · Cited by 2
Diabetes Fact Sheet 2025: Special Edition on Diabetes with Obesity and in Pregnancy
Park, S. E., Min, S. H., Kim, J. Y., Lee, S.-H., Jung, H. N., MOON, J. H., Han, K., Ko, S., Soo, B., & Choi, S. H. (2026) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.1162 · Cited by 4
“The stepwise gradient in age and metabolic indices (no diabetes in pregnancy GDM PGDM) aligns with a continuum of dysglycemia that often predates conception and becomes unmasked or exacerbated during gestation [35].”
Wang, L., Sheng, H., Jiang, C., & Chen, Y. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07719-5 · Cited by 3
“The primary mechanisms include increased insulin resistance and pancreatic β-cell dysfunction, as well as a multitude of other factors, including adipokines, inflammatory mediators, and placental function [7–9].”
Gestational diabetes and its effect on fetal thymus size: a case–control study
Mansouri, N., Khezripour, E., Rashtiani, N., Bagherinia, M., & Azizi, A. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07468-5 · Cited by 3
“Less insulin sensitivity may be caused by more hormones that cause diabetes, like placental lactogen, progesterone, and cortisol, although the precise mechanisms underlying these changes remain incompletely understood [9].”
Prenatal Vitamin D Deficiency and Maternal and Fetal Health Outcomes
Tsenkova-Toncheva, L., Hristova-Atanasova, E., Iskrov, G. G., & Stefanov, R. S. (2024) · Cureus · doi:10.7759/cureus.69508 · Cited by 9
Rincón‐Guevara, O., Wallace, B., Kompaniyets, L., Barrett, C. E., & Bull–Otterson, L. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae416 · Cited by 5
Investigating genetic links between biological aging and adverse pregnancy outcomes
Sun, N., Yang, K., Wang, H., & Zhou, W. (2025) · Biogerontology · doi:10.1007/s10522-025-10198-y · Cited by 2
“Our study demonstrated significant positive causal associations between FI and the risks of GDM, HTP and PL. GDM is a significant pregnancy complication in which women with previously undiagnosed diabetes experience chronic hyperglycemia during pregnancy (Plows et al. 2018).”
Ma, Z., Qin, Z., Ji, Y., Zou, M., & Li, M. (2025) · Diabetes and Vascular Disease Research · doi:10.1177/14791641251335918 · Cited by 3
“Logistic regression analysis was used to evaluate whether lncRNA SNHG14 and miR-493-5p were independent factors for the occurrence of GDM. Pearson ’ s correlation coef fi cient was used to determine the correlation between lncRNA SNHG14 and miR-493-5p.”
InfluentialSedgi, F. M., Hassani, A. H., Faghfouri, A. H., Gheibi, S., Mohammadpour, Y., & Mokari‐Yamchi, A. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02028-6 · Cited by 2
“Key risk factors for GDM include overweight or obesity, a Westernized diet, micronutrient deficiencies, advanced maternal age, and a family history of insulin resistance or diabetes [9].”
Arab, S., Binmahfooz, S., Abualsaud, R., Basuliman, A. A., Qurain, R., AlSaidlani, R. H., Alsharif, S. T., Alsaiari, M., & Awami, H. (2023) · Cureus · doi:10.7759/cureus.44273 · Cited by 4
“The effects of GDM include a higher risk for cardiovascular disease in mothers, T2DM, macrosomia, and child delivery difficulties [6].”
BackgroundHe, T., Chen, J., Zheng, J., Li, H., Ma, D., Wang, L., Mao, J., Luo, J., & Yang, Z. (2026) · Food & Function · doi:10.1039/d5fo05140a · Cited by 3
Aayush, M. V., Nikthesh, G., Rajmohan, D., Ravindran, C. P., Vasantharekha, R., Thangavelu, S., & Seetharaman, B. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111693 · Cited by 4
Association between sleep quality with maternal and neonatal outcomes during the covid-19 pandemic
Akbari, M., EsmaeilzadehSaeieh, S., Farid, M., Shafiee, A., Bakhtiyari, M., Babaheidari, T. B., & Yazdkhasti, M. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06479-y · Cited by 4
“Since pregnancy itself is associated with insulin resistance [16], changes in sleep patterns may further increase pregnant women’s likelihood of experiencing high blood sugar levels [17, 18].”
BackgroundMutual effects of gestational diabetes and schizophrenia: how can one promote the other?: A review
Ghamri, K. A. (2024) · Medicine · doi:10.1097/md.0000000000038677 · Cited by 3
“[25] β -cell failure may stem from various genetic deficiencies, such as in the potassium voltage-gated channel, KQT-like superfamily, member 1, [26,27] glucokinase, [28] prolactin receptor, [29] and forkhead box protein M1.”
BackgroundWang, J., Wang, L., & Qiu, H. (2024) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/174347 · Cited by 2
Sridhar, V. S., Liu, H., Lovblom, L. E., Feig, D. S., Herer, E., Hladunewich, M., Kiss, A., Kohly, R. P., Lipscombe, L. L., Yip, P. S. F., et al. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.07.004 · Cited by 2
Atkinson, J., Dongarwar, D., Mercado-Evans, V., Hernandez, A., Deslandes, A., Gonzalez, M. A., Sherman, D., & Salihu, H. M. (2022) · Southern Medical Journal · doi:10.14423/smj.0000000000001418 · Cited by 3
“The data also suggest that children born to mothers with GDM are at increased risk for obesity, cardiovascular disease, and type 2 DM later in life.(3,4)Womenwith PDM are reported to be at a significantly increased risk for preeclampsia, congenital malformations, fetal overgrowth, and fetal death.”
BackgroundСергеевна, С. А., Rodina, A. V., Сергеевич, К. К., Zakharov, A. D., & Durnev, A. D. (2023) · Pharmacokinetics and Pharmacodynamics · doi:10.37489/2587-7836-2023-2-45-53 · Cited by 3
Modern aspects of gestational diabetes mellitus: definition, risk factors
Негматуллаева, М. Н., Туксанова, Д. И., & Насырова, Ш. Ш. (2025) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20252502135 · Cited by 4
Functional genetic variants and susceptibility and prediction of gestational diabetes mellitus
Huang, G., Sun, Y., Li, R., Mo, L., Liang, Q., & Yu, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-69079-y · Cited by 5
“This finding is consistent with the findings of numerous previous studies 8,10,13,14,19–21 .”
ResultStennett, R., Gerstein, H. C., Bangdiwala, S. I., Rafiq, T., Teo, K. K., Morrison, K. M., Atkinson, S. A., Anand, S. S., & de Souza, R. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302208 · Cited by 3
Pros and cons of live kidney donation in prediabetics: A critical review and way forward
Khalil, M. A. M., Sadagah, N. M., Tan, J. C., Syed, F. O., Chong, V. H., & Al-Qurashi, S. H. (2024) · World Journal of Transplantation · doi:10.5500/wjt.v14.i1.89822 · Cited by 2
Histochemical Study of Human Placental Tissues in Gestational Diabetic Mellitus
Lafta, I. A., Abdulhameed, W. A., & Al-Bakri, N. A. (2021) · Iraqi Journal of Embryos and Infertility Researches · doi:10.28969/ijeir.v10.i2.r3 · Cited by 2
“Figure (2): GDM placenta showing: moderate reactive, areas of glycogen deposition (arrow) (PAS stain ,40X)”
BackgroundInfluentialEvaluation of Protein Oxidation Parameters in Women with Pregnancy Complications
Science, C. (2021) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2021.72125.3685 · Cited by 3
Adipokines in gestational diabetes
Łopuszyńska, A. M., Ochyra, Ł., Pawlicki, M., & Piecewicz‐Szczęsna, H. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.11.037 · Cited by 2
“Moreover, placental production of this adipokine is also increased, which facilitates the transport of amino acids across the placenta and causes fetal macrosomia [9].”
BackgroundDoğan, Y., Arslan, O. A., Öztaş, B., Kurtali, A., Daryal, A. S., & Eser, M. D. (2024) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2023.2300981 · Cited by 3
“Advanced maternal age is a well-established risk factor for GDM and as expected, our study cohort revealed that individuals with diabetes had a higher mean age [20].”
BackgroundUnraveling the Nutritional Perspectives of Probiotics and Prebiotics in Female Healthcare
Kumari, N., Pal, Y., Tailor, C. S., Negi, D., Syan, J., Badhani, A., & Pal, R. S. (2025) · Recent Advances in Food Nutrition & Agriculture · doi:10.2174/012772574x374047250325183211 · Cited by 3
Placental Adaptations to Pregnancy Comorbidities in Fetal Congenital Heart Disease
Baldauf, C., Desmond, A., León, R. L., & Rajagopalan, V. (2025) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-025-01096-0 · Cited by 2
Fetal Risks and Morbidity in Pregnant Individuals with Obesity
Wang, T. L., & Feghali, M. N. (2023) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-023-00347-w · Cited by 2
ABO blood groups are not associated to gestational diabetes mellitus in Mexican women
Cordero-Franco, H. F., Salinas-Martínez, A. M., Esparza-Contró, M. J., González-Rueda, S. D., & Garza, F. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292493 · Cited by 2
AlShaibani, T., Gherbal, W., Almarabheh, A. J., Rizk, D. E. E., Alhakmani, E., Alshamrani, R. K., AlBahraini, F., Taha, H., Hassani, A., & Naguib, Y. M. (2024) · Cureus · doi:10.7759/cureus.64886 · Cited by 2
“All these factors may raise the probability of developing GDM [1,2,4].”
BackgroundInfluentialGestational Diabetes and Infertility
Turan, G. A., & Delibaşı, T. (2023) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2023.132016 · Cited by 2
Pregnancy Complications and Outcomes in Obese Women with Gestational Diabetes
Ramonienė, G., Malakauskienė, L., Savukynė, E., Maleckienė, L., & Gruzdaitė, G. (2025) · Medicina · doi:10.3390/medicina61010051 · Cited by 7
Huang, Y., Cai, F., Zhang, W., Shen, R., & Jin, L. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-6223 · Cited by 3
“In addition to the impairment of the secretion of insulin, some studies have revealed that inflammation also plays a crucial role in the pathogenesis of GDM (15-18).”
BackgroundGestational diabetes mellitus and obesity: effects on offspring
Рожкова, О. В., Ремнева, О. В., Фадеева, Н. И., Korenovskiy, Y. V., & Yavorskaya, S. D. (2021) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2021.197 · Cited by 2
“В их основе лежат нарушения процессов как секреции инсулина, так и изменение чувствительности тканей к инсулину [4].”
Xu, M., Tang, L., & Wang, Y. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06846-9 · Cited by 4
“Studies have shown that patients with GDM typically exhibit a state of low-grade inflammation [4], with elevated levels of pro-inflammatory cytokines.”
BackgroundFrom Pregnancy to Postpartum: The Cardiovascular Risks Associated with Gestational Diabetes
Sharma, R., Singh, U., Kamal, R., & Kumar, R. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x354645250329171327 · Cited by 4
“They either cause the IRS-1 to be degraded via the STAT3-SOCS3 pathway, enhance serine protein phosphorylation of IRS-1, or inhibit actions of tyrosine of the insulin-related receptor (IR) [74, 75].”
Su, Y., Wang, L., & He, D. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114670 · Cited by 3
Li, Y., Zhang, T., Ma, J., Ma, R., Liu, J., Xu, J., Rothenberg, S. E., Yan, C., Zhang, J., Luo, Z., et al. (2025) · Environment International · doi:10.1016/j.envint.2025.109959 · Cited by 3
Vitamin D Prevents Gestational Diabetes Mellitus via Modulating Glucose Metabolism in a Mouse Model
Gu, S., Chen, S., & Liu, Y. (2024) · Physiological Research · doi:10.33549/physiolres.935287 · Cited by 3
Are miR‐26a and miR‐26b microRNAs potent prognostic markers of gestational diabetes?
Ghaneialvar, H., Mohseni, M. M., Kenarkoohi, A., & Kakaee, S. (2024) · Health Science Reports · doi:10.1002/hsr2.2152 · Cited by 4
“6,15,16 The pathology of GDM is still not fully understood.”
BackgroundJiang, J., Wei, S., Chen, M., Tan, Y., Yang, Z., Yang, G., Feng, W., Han, Z., Wei, X., & Luo, X. M. (2024) · Biomedicines · doi:10.3390/biomedicines12051128 · Cited by 3
“For example, the condition is mediated by placenta factors in GDM patients, and the development process of GDM is shorter than that of T2DM (most GDM patients can recover within weeks after delivery) [30].”
BackgroundAssessment of Serum Neuregulin 4 Level and Several Metabolic Parameter in Gestational Diabetes
Bayati, M. M. A. (2023) · International Journal of Research in Medical Sciences & Technology · doi:10.37648/ijrmst.v16i01.012 · Cited by 2
Correlation between plasma Afamin and gestational diabetes mellitus during pregnancy
Cheng, X. R., Cui, H., Xu, X., & Jiang, N. (2025) · Ginekologia Polska · doi:10.5603/gpl.103660 · Cited by 2
Zermane, H., & Kalla, A. (2024) · Ars medica tomitana · doi:10.2478/arsm-2024-0007 · Cited by 2
Şahin, M., Görkem, Ü., Bilgi, A., & Dikker, O. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14857 · Cited by 5
Zhu, H., Cai, J., Xu, Q., Xu, L., He, D., Chen, X., Chen, T., Wang, P., Li, Y., Ye, W., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-09615-w · Cited by 4
“The simultaneous activation of multiple immune pathways likely contributes to the chronic in fl ammatory state that exacerbates insulin resistance and metabolic dysfunction 77,78 .”
Advances in Research on Aging in Female Infertility and Pathologic Pregnancy
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4798-4 · Cited by 2
Chen, N., Shi, S., Xu, H., Zhao, S., Hong, L., Zeng, C., Huang, Y., Shen, L., Wang, D., & Wang, Z. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1706588 · Cited by 2
“GDM confers substantial short-term risks, including preeclampsia and caesarean delivery for mothers, and macrosomia, neonatal hypoglycemia, and respiratory distress for infants (Plows et al., 2018; Simmons et al., 2024; Thornton et al., 2023).”
Rosta, K., Al-Bibawy, K., Al-Bibawy, M., Temsch, W., Springer, S., Somogyi, A., & Ott, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072249 · Cited by 2
“Indeed, higher placental mass—which correlates with these hormones—might be responsible for this effect [29].”
BackgroundMethodGether, I. M., Andersen, E. S., Foghsgaard, S., Ellegaard, A., Kelstrup, L., Sonne, D. P., Brønden, A., Gillum, M. P., Holst, J. J., Hartmann, B., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16064 · Cited by 2
Myeloid‐derived suppressor cells: Are they involved in gestational diabetes mellitus?
Hua, S., Wang, S., Cai, J., Wu, L., & Cao, Y. (2023) · American Journal of Reproductive Immunology · doi:10.1111/aji.13711 · Cited by 3
Anudeep, D. D. S., Pati, S., Sajjan, S., Koppal, D., & Kolekar, P. (2025) · Cureus · doi:10.7759/cureus.84198 · Cited by 2
Yu, J. S., Kim, O., Kang, B. S., Lee, S. U., Lee, Y. J., Hwang, H. S., Lee, S. M., Kim, S. C., Choi, Y., & Ko, H. S. (2024) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580241252569 · Cited by 2
Insulin resistance unraveled: Hormonal correlations in gestational diabetes
Chen, S., Bai, X., Yin, X., & Bai, L. (2024) · Journal of Medical Biochemistry · doi:10.5937/jomb0-49981 · Cited by 7
“The underlying cause of the disease is insulin resistance and/or defective pancreatic b -cells in the body (10).”
BackgroundThe effect of gestational diabetes on maternal and neonatal outcomes
Wang, C.-W., Chen, H., Chen, C.-Y., Chiu, H.-Y., Chu, K.-H., Hsiao, Y.-H., Huang, M., & Lai, J. C. (2026) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2025.02.007 · Cited by 3
Binbin, Z. H. A. O., Ge, L., Kong, Y., Lai, Y.-T., Yiru, L. I. U., Huang, P., Lan, H. A. O., Chen, F., LIANG, S., & Dai, Y. (2021) · Rehabilitation Medicine · doi:10.3724/sp.j.1329.2021.06002 · Cited by 2
Gestational diabetes mellitus: a (nearly) perfect mouse model
Blysniuk, N., Visram, A., & Lam, K. T. (2019) · The Journal of Physiology · doi:10.1113/jp278570 · Cited by 2
“As pregnancy progresses, the surge of pregnancy hormones including prolactin, progesterone and placental lactogen promote a temporary state of mild insulin resistance, allowing blood glucose to remain high and supply the fetus via the placenta (Plows et al. 2018).”
BackgroundHu, G. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002383 · Cited by 4
“Thus, the pathogenesis of GDM is usually considered as IR, glucose intolerance, and decreased b-cell function during pregnancy.([24-26]) Several studies have assessed the association of maternal glucose and IR during pregnancy with the risk of adverse pregnancy outcomes amongwomenwithGDM.”
BackgroundRol de la metformina en el tratamiento de la diabetes mellitus gestacional: situación actual
Miranda, P. J. P., Palacios, L. P. T., Cueva, J. L. C., Avilés, G. A. H., Maldonado, E. I. B., Moya, J. I. E., Moya, J. R. E., Acosta, J. M. S., & Lozada, E. M. V. (2019) · Archivos Venezolanos de Farmacología y Terapéutica · Cited by 10
Ustianowski, P., Malinowski, D., Czerewaty, M., Safranow, K., Tarnowski, M., Dziedziejko, V., & Pawlik, A. (2022) · Genes · doi:10.3390/genes14010083 · Cited by 2
“Previous studies have indicated that metabolic syndrome and inflammation are also factors that increase the risk of developing GDM [3].”
BackgroundWang, J., Xie, Z., Chen, P., Wang, Y., Li, B., & Dai, F. (2022) · Open Life Sciences · doi:10.1515/biol-2022-0006 · Cited by 3
Zhao, M., Bian, X., & Meng, L. (2024) · Reproductive Biology · doi:10.1016/j.repbio.2024.100861 · Cited by 3
Kiryowa, H. M., Buwembo, W., Munabi, I. G., Mwaka, E., Rwenyonyi, C. M., Kaddumukasa, M., & Kiguli, S. (2024) · BMC Research Notes · doi:10.1186/s13104-024-06804-w · Cited by 2
Santos, G., de Souza, F. D., Montero, M. F., Jordão, M. C., Oliveira, M. C. M., Janovsky, C. C. P. S., Mattar, R., Dib, S. A., Dualib, P. M., & de Almeida-Pititto, B. (2025) · Cureus · doi:10.7759/cureus.85505 · Cited by 5
“It is associated with several risk factors, including overweight, obesity, advanced maternal age, and a prior history of GDM [3].”
Fan, X., Zhang, P., Wang, L., Song, W., Su, A., & Yu, T. (2025) · PeerJ · doi:10.7717/peerj.18965 · Cited by 2
“Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy ( Plows et al., 2018 ).”
Evaluation of Anti-Diabetic Activity of Galinosa parviflora in Diabetic Rats
Dhakad, G. G., Mohale, D., & Chandewar, A. V. (2024) · Research Journal of Pharmacology and Pharmacodynamics · doi:10.52711/2321-5836.2024.00025 · Cited by 3
Li, L., Mu, Y.-C., Wang, D.-W., Du, J., Zhang, Z., & Wang, F. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i1.112690 · Cited by 3
Хара, М. Р., Korda, I. V., & Podilska, T. I. (2023) · Pathologia · doi:10.14739/2310-1237.2023.2.282626 · Cited by 3
“When this inability is combined with reduced insulin sensitivity, persistent hyperglycemia develops, which can be leveled after childbirth or develop into type 2 diabetes [6,7].”
Background
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.